JERSAZE

Glaxo Group Limited

Application Filed: 2007-04-27

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	77167740
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	GlaxoSmithKline
Attorney Name	Maribeth Day Case
Attorney Docket Number	App/JERSAZE/
Law Office Assigned	L50
Employee Name	BUSH, KAREN K

Timeline

2007-04-27	Application Filed
2007-10-23	Published for Opposition
2009-01-05	Location: INTENT TO USE SECTION
2011-02-14	Abandon
2011-02-14	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Glaxo Group Limited
Address	Glaxo Wellcome House Berkeley Avenue Greenford, Middles UB60NN GB2
Legal Entity Type	Corporation
Legal Entity State	GB2

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Maribeth Day Case
GLAXOSMITHKLINE
LGTM, C.3157.3D
FIVE MOORE DRIVE
RESEARCH TRIANGLE PARK NC 27709

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines

Type Code

Type

GS0051

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2007-05-02	1 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2007-08-10	2 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2007-08-10	3 CNSA P:
ASSIGNED TO LIE	2007-09-18	4 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2007-09-18	5 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2007-10-03	6 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2007-10-23	7 PUBO A:Allowance for Publication
ASSIGNED TO EXAMINER	2007-10-25	8 DOCK D:Assigned to Examiner
NOA MAILED - SOU REQUIRED FROM APPLICANT	2008-01-15	9 NOAM O:Outgoing Correspondence
TEAS EXTENSION RECEIVED	2008-05-29	10 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2008-05-29	11 EXT1 S:
EXTENSION 1 GRANTED	2008-05-29	12 EX1G S:
TEAS EXTENSION RECEIVED	2008-12-15	13 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2009-01-05	14 AITU A:Allowance for Publication
EXTENSION 2 FILED	2008-12-15	15 EXT2 S:
EXTENSION 2 GRANTED	2009-01-05	16 EX2G S:
TEAS EXTENSION RECEIVED	2009-06-16	17 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2009-06-16	18 EXT3 S:
EXTENSION 3 GRANTED	2009-06-17	19 EX3G S:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2009-07-06	20 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2009-07-06	21 ARAA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2009-10-26	22 TCCA I:Incoming Correspondence
TEAS EXTENSION RECEIVED	2009-12-11	23 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2009-12-11	24 EXT4 S:
EXTENSION 4 GRANTED	2009-12-17	25 EX4G S:
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2010-05-13	26 TCCA I:Incoming Correspondence
TEAS EXTENSION RECEIVED	2010-07-06	27 EEXT I:Incoming Correspondence
EXTENSION 5 FILED	2010-07-06	28 EXT5 S:
EXTENSION 5 GRANTED	2010-07-12	29 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2010-07-13	30 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2011-02-14	31 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2011-02-14	32 MAB6 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
JERSAZE 88191373 5763561 Live/Registered	Glaxo Group Limited 2018-11-13
JERSAZE 85214751 not registered Dead/Abandoned	Glaxo Group Limited 2011-01-11
JERSAZE 77167740 not registered Dead/Abandoned	Glaxo Group Limited 2007-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.